What does Anxu do?

Hangzhou Anxu Bio-technology Co., Ltd. focuses on the research and development, production and sales of POCT reagents and instruments, with the biological raw material technology platform of independent research and development and production of antigen and antibody, as well as mature immunochromatographic and dry biochemical diagnostic technology platform, and has developed a POCT reagents covering eight major fields such as drug testing, infectious disease testing, chronic disease testing, pregnancy testing, tumor testing, cardiac testing, biochemical testing, allergen testing and so on. We have developed POCT reagents covering eight major fields such as drug testing, infectious disease testing, pregnancy testing, tumor testing, cardiac testing, biochemical testing and allergen testing.

One, the company's mission:

Provide excellent products and services for human health, vision: to become the industry's evergreen tree, values: customer first, sustainable management; people-oriented, integrity and dedication; down-to-earth, stargazing; unity and progress, cooperation and innovation.

Second, the scope of business:

Manufacturing, processing: non-medical biological materials and agricultural testing products, the first, second, third class medical devices; wholesale and retail: the first, second, third class medical devices, pharmaceutical intermediates; services: biological products technology, computer software technology development, results transfer, technical consulting, technical services, import and export of goods (except for projects prohibited by laws and regulations, national laws and regulations) Prohibited items are excluded; items restricted by national laws and regulations can only be operated after obtaining a license). (Items subject to approval by law can only be operated after approval by relevant departments).

Three achievements:

At present, Anxu Bio owns 16,000 square meters of production and R&D bases, and has set up the production line of colloidal gold rapid diagnostic reagents and the production line of POCT integrated instruments with international leading level. Anxu Bio is in the domestic leading level in the fields of rapid diagnostic reagent platform, molecular rapid diagnostic platform, immunoantibody development and preparation, small molecule antigen synthesis and genetic engineering. We have successfully developed more than 100 kinds of products in 9 series, including pregnancy, drugs, infectious diseases, tumor markers, food safety, biochemical series and integrated instruments and reagents.

Anxu products and related technologies have obtained 60 patents at home and abroad, 35 registered trademarks at home and abroad, 21 domestic registration certificates for Class II and Class III medical devices, and internationally passed the certification of U.S.A. FDA, European Union CE, Canada CMDCAS, and five countries joint MASAP.

At present, Anxu Bio has already owned the high-end microbiology lab and biosafety lab in the industry, and has established a wide range of industry-academia-research cooperation with Zhejiang University, Ohio State University and other colleges and universities, and Anxu Bio's products are sold well in more than 130 countries and regions in Europe and the United States, Asia, Africa, Oceania and so on.